Skip to content

Study the Effect of Danggui Buxue Tang on Menopausal Symptoms

A Randomized, Double-Blind, Placebo Controlled Study of the Effect of Danggui Buxue Tang on Menopausal Symptoms and Quality of Life in Hong Kong Chinese Women

Status
Completed
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00421564
Enrollment
100
Registered
2007-01-12
Start date
2003-02-28
Completion date
2004-12-31
Last updated
2007-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Menopause

Keywords

Menopausal, Traditional Chinese Medicine

Brief summary

This study is to examine the effect and safety of the study drug,Danggui Buxue Tang, on menopausal symptoms of hot flushes and sweating and to determine whether the patient's quality of life will be improved.

Interventions

Sponsors

Chinese University of Hong Kong
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Follicle stimulating hormone (FSH), luteinizing hormone (LH), oestradiol in the menopausal range (FSH\>18 IU/L, LH\>12.6 IU/L, and E2\< 361 pmol/l). * Patients with amenorrhoea for more than 12 months

Exclusion criteria

* Patients with a history of using any form of hormonal replacement therapy within 8 weeks * Patients with a history of using Chinese medicine or other therapies which may affect the outcome within 8 weeks * Patients who in the judgment of the investigator will be unable to comply with protocol requirements * Patients with significant\*\* gastrointestinal, renal, hepatic, bronchopulmonary, neurological, cardiovascular, breast or endometrial carcinoma, or allergic diseases * Patients with uncontrolled hypertension * Patients with undiagnosed vaginal bleeding * Patients with a history of significant drug hypersensitivity

Design outcomes

Primary

MeasureTime frame
The Changes in severity and frequency of hot flushes and sweats.

Secondary

MeasureTime frame
The Changes in score of the Menopause Specific Quality of Life and the values of various markers of risk for cardiovascular disease.

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026